End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18,820 KRW | +0.64% | +3.75% | -8.86% |
Apr. 24 | Korean Sugar Imports Plunge 14% as Diabetes Cases Surge | MT |
Mar. 08 | Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 348
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
108.1
%
| 1,832,140 | 107.9 % | 1,961,127 | 108.1 % | +7.04% |
Consolidation Adjustment
-15.5
%
| -246,498 | -14.5 % | -281,032 | -15.5 % | +14.01% |
Service
6.3
%
| 96,960 | 5.7 % | 114,120 | 6.3 % | +17.70% |
Real Estate Lease
0.6
%
| 6,308 | 0.4 % | 10,863 | 0.6 % | +72.21% |
Others
0.5
%
| 8,428 | 0.5 % | 8,763 | 0.5 % | +3.97% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
76.7
%
| 1,701,044 | 100.2 % | 1,390,446 | 76.7 % | -18.26% |
International
38.8
%
| 242,792 | 14.3 % | 704,428 | 38.8 % | +190.14% |
Consolidation Adjustment
-15.5
%
| -246,498 | -14.5 % | -281,032 | -15.5 % | +14.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 85-07-31 |
Chang-Jae Lee
BRD | Director/Board Member | 47 | 02-11-30 |
Woo-Bang Jeon
AUD | Comptroller/Controller/Auditor | 63 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Cheol Kang
BRD | Director/Board Member | 67 | 22-03-28 |
Jae-Chun Yoon
CEO | Chief Executive Officer | 64 | 85-07-31 |
Geon-Haeng Lee
BRD | Director/Board Member | 63 | - |
Chang-Jae Lee
BRD | Director/Board Member | 47 | 02-11-30 |
Jong-Guk Kim
BRD | Director/Board Member | 63 | 18-02-28 |
Hoon-Seok Lee
BRD | Director/Board Member | 59 | 22-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,141,980 | 18,561,757 ( 31.92 %) | 17,251,270 ( 29.67 %) | 31.92 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
6,058,200 | 52.29% | 545,856,785 $ | |
DAEWOONG CO., LTD. 28.48% | 16,560,640 | 28.48% | 248,486,441 $ |
AEON BIOPHARMA, INC. 17.70% | 6,577,604 | 17.70% | 76,300,206 $ |
246,240 | 1.04% | 956,610 $ |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.86% | 556M | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.31B |
- Stock Market
- Equities
- A003090 Stock
- Company Daewoong Co., Ltd.